No connection

Search Results

GOSS vs WW

GOSS
Gossamer Bio, Inc.
BEARISH
Price
$0.37
Market Cap
$87.2M
Sector
Healthcare
AI Confidence
95%
WW
WW International, Inc.
BEARISH
Price
$9.29
Market Cap
$92.9M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
GOSS
--
WW
1.23
Forward P/E
GOSS
-2.23
WW
-16.02
P/B Ratio
GOSS
-0.71
WW
0.29
P/S Ratio
GOSS
1.8
WW
0.13
EV/EBITDA
GOSS
-0.94
WW
2.7

Profitability

Gross Margin
GOSS
100.0%
WW
71.72%
Operating Margin
GOSS
-333.65%
WW
-5.38%
Profit Margin
GOSS
0.0%
WW
148.6%
ROE
GOSS
--
WW
--
ROA
GOSS
-41.86%
WW
6.74%

Growth

Revenue Growth
GOSS
47.1%
WW
-11.7%
Earnings Growth
GOSS
--
WW
--

Financial Health

Debt/Equity
GOSS
--
WW
1.47
Current Ratio
GOSS
2.64
WW
1.69
Quick Ratio
GOSS
2.36
WW
1.4

Dividends

Dividend Yield
GOSS
--
WW
--
Payout Ratio
GOSS
0.0%
WW
0.0%

AI Verdict

GOSS BEARISH

GOSS exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating the weakest possible fundamental health. The company suffers from negative equity (Price/Book of -0.71) and an unsustainable operating margin of -333.65%. Despite positive revenue growth, the stock is in a catastrophic technical death spiral, losing over 85% of its value in the last six months. The massive discrepancy between the current price ($0.37) and the analyst target ($3.69) suggests a significant lag in analyst updates or extreme speculative optimism not supported by the deterministic data.

Strengths
Strong YoY revenue growth of 47.10%
Healthy short-term liquidity with a Current Ratio of 2.64
Quick Ratio of 2.36 suggests immediate obligations can be met
Risks
Negative Book Value (P/B -0.71) indicating liabilities exceed assets
Piotroski F-Score of 0/9 signals severe fundamental deterioration
Extreme price decay with a 5-year decline of 95.6%
WW BEARISH

WW presents as a classic value trap; while the Piotroski F-Score is stable (5/9) and the stock trades at a massive discount to its Graham Number ($73.68) and Intrinsic Value ($53.06), the fundamental trajectory is alarming. Revenue is declining (-11.7% YoY), and the forward P/E is negative (-16.02), indicating expected losses. The extreme bearish price momentum (-65.6% over 1 year and -46.6% over 1 month) suggests the market is pricing in a structural decline that deterministic value formulas are failing to capture.

Strengths
Extremely low valuation multiples (P/S 0.13, P/B 0.29)
Strong Gross Margin of 71.72%
Stable Piotroski F-Score of 5/9
Risks
Negative forward earnings expectations (Forward P/E -16.02)
Consistent revenue contraction (-11.7% YoY)
Severe price collapse (-69.4% in 6 months)

Compare Another Pair

GOSS vs WW: Head-to-Head Comparison

This page compares Gossamer Bio, Inc. (GOSS) and WW International, Inc. (WW) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile